Hydroxysafflor yellow A suppress oleic acid-induced acute lung injury via protein kinase A

Toxicology and Applied Pharmacology

Volumn 272, Issue 3, 2013, Pages 895-904

  Wang, Chaoyun ^a   Huang, Qingxian ^b   Wang, Chunhua ^a   Zhu, Xiaoxi ^a   Duan, Yunfeng ^a   Yuan, Shuai ^a   Bai, Xianyong ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Acute lung injury; CAMP; Hydroxysafflor yellow A; Nicotinamide adenine dinucleotide phosphate oxidase; Protein kinase A; ROS

Indexed keywords

CASPASE 3; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; FLAVONOID; GLUTATHIONE PEROXIDASE; HYDROXYSAFFLOR YELLOW A; INTERLEUKIN 10; INTERLEUKIN 6; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OLEIC ACID; OXYGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHALCONE; DRUG DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; PROTEIN KINASE INHIBITOR; QUINONE DERIVATIVE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD PH; CARBON DIOXIDE TENSION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG LAVAGE; LUNG WEIGHT; MALE; NONHUMAN; OXIDATIVE STRESS; OXYGEN BLOOD LEVEL; PROTEIN BLOOD LEVEL; RAT; SIGNAL TRANSDUCTION; WATER CONTENT; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; PHYSIOLOGY; RANDOMIZATION; ROS; SPRAGUE DAWLEY RAT; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; TOXICITY;

ACUTE LUNG INJURY; CAMP; HYDROXYSAFFLOR YELLOW A; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; PROTEIN KINASE A; ROS;

ACUTE LUNG INJURY; ANIMALS; CHALCONE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; MALE; OLEIC ACID; PROTEIN KINASE INHIBITORS; QUINONES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84885224856     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.07.021     Document Type: Article

References (49)

1. Altintas N.D., Atilla P., Iskit A.B., Topeli A. Long-term simvastatin attenuates lung injury and oxidative stress in murine acute lung injury models induced by oleic acid and endotoxin. Respir. Care 2011, 56:1156-1163.
2. Avni D., Ernst O., Philosoph A., Zor T. Role of CREB in modulation of TNFalpha and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Mol. Immunol. 2010, 47:1396-1403.
3. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
4. Bengis-Garber C., Gruener N. Protein kinase A downregulates the phosphorylation of p47phox in human neutrophils: a possible pathway for inhibition of the respiratory burst. Cell. Signal. 1996, 8:291-296.
5. Bhatia M., Zemans R.L., Jeyaseelan S. Role of chemokines in the pathogenesis of acute lung injury. Am. J. Respir. Cell Mol. Biol. 2012, 46(5):566-572.
6. Cai H., Griendling K.K., Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 2003, 24:471-478.
7. Castro A., Jerez M.J., Gil C., Martinez A. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors. Med. Res. Rev. 2005, 25:229-244.
8. Davidson T.A., Caldwell E.S., Curtis J.R., Hudson L.D., Steinberg K.P. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 1999, 281:354-360.
9. Davidson K.G., Bersten A.D., Barr H.A., Dowling K.D., Nicholas T.E., Doyle I.R. Lung function, permeability, and surfactant composition in oleic acid-induced acute lung injury in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L1091-L1102.
10. Delbosc S., Paizanis E., Magous R., Araiz C., Dimo T., Cristol J.P., Cros G., Azay J. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 2005, 179:43-49.
11. Dickey B.F., Thrall R.S., McCormick J.R., Ward P.A. Oleic-acid-induced lung injury in the rat. Failure of indomethacin treatment or complement depletion to ablate lung injury. Am. J. Pathol. 1981, 103:376-383.
12. Didion S.P., Ryan M.J., Didion L.A., Fegen P.E., Sigmund C.D., Faraci F.M. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ. Res. 2002, 91:938-944.
13. Fan L., Dang X., Shi Z., Zhang C., Wang K. Hydroxysafflor yellow A protects PC12 cells against the apoptosis induced by oxygen and glucose deprivation. Cell. Mol. Neurobiol. 2011, 31:1187-1194.
14. Fu Z.H., Yang Z.C., Li A., Liu Z.X., Wu J.P. Study on transcriptional regulation of oxidative stress on expression of surfactant protein A. Chin. J. Traumatol. (Chin.) 2000, 16:610-612.
15. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., Barnes J.L., Abboud H.E. NOX4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 2005, 280:39616-39626.
16. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 2000, 86:494-501.
17. He H., Yang X., Shi M., Zeng X., Yang J., Wu L., Li L. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats. J. Pharm. Pharmacol. 2008, 60:115-123.
18. Ishitsuka Y., Moriuchi H., Yang C., Kurita S., Golbidi S., Irikura M., Irie T. Preventive effect of tranilast on oleic acid-induced lung injury in guinea pigs. Biol. Pharm. Bull. 2004, 27:1451-1454.
19. Kim C., Cheng C.Y., Saldanha S.A., Taylor S.S. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation. Cell 2007, 130:1032-1043.
20. Koh G., Suh K.S., Chon S., Oh S., Woo J.T., Kim S.W., Kim J.W., Kim Y.S. Elevated cAMP level attenuates 2-deoxy-d-ribose-induced oxidative damage in pancreatic-cells. Arch. Biochem. Biophys. 2005, 438:70-79.
21. Krause K.H., Bedard K. NOX enzymes in immuno-inflammatory pathologies. Semin. Immunopathol. 2008, 30:193-194.
22. Lang J.D., Figueroa M., Chumley P., Aslan M., Hurt J., Tarpey M.M., Alvarez B., Radi R., Freeman B.A. Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium. Anesthesiology 2004, 100:51-58.
23. Lassègue B., Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R277-R297.
24. Li H.X., Zhang J.S., Zhao Y.L., Hao H.J. Effects of interleukin-10 on expression of inflammatory mediators and anti-inflammatory mediators during acute lung injury in rats. Chin. Crit. Care Med. 2005, 17:338-341.
25. Lorne E., Zmijewski J.W., Zhao X., Liu G., Tsuruta Y., Park Y.J., Dupont H., Abraham E. Role of extracellular superoxide in neutrophil activation: interactions between xanthine oxidase and TLR4 induce proinflammatory cytokine production. Am. J. Physiol. Cell Physiol. 2008, 294:C985-C993.
26. Maulik N., Das D.K. Redox signaling in vascular angiogenesis. Free Radic. Biol. Med. 2002, 33:1047-1060.
27. McAuley D.F., Matthay M.A. Is there a role for b-adrenoceptor agonists in the management of acute lung injury and the acute respiratory distress syndrome?. Treat. Respir. Med. 2005, 4:297-307.
28. Mistrík E., Dusilová-Sulková S., Bláha V., Sobotka L. Plasma albumin levels correlate with decreased microcirculation and the development of skin defects in hemodialyzed patients. Nutrition 2010, 26:880-885.
29. Mitra S., Abraham E. Participation of superoxide in neutrophil activation and cytokine production. Biochim. Biophys. Acta 2006, 1762:732-741.
30. Moriuchi H., Zaha M., Fukumoto T., Yuizono T. Activation of polymorphonuclear leukocytes in oleic acid-induced lung injury. Intensive Care Med. 1998, 24:709-715.
31. Mukhopadhyay S., Hoidal J.R., Mukheriee T.K. Role of TNF alpha in pulmonary pathophysiology. Respir. Res. 2006, 7:125.
32. Muller J., Huaux F., Moreau N., Misson P., Heilier J.F., Delos M., Arras M., Fonseca A., Nagy J.B., Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 2005, 207:221-231.
33. Natarajan M., Lin K.M., Hsueh R.C., Sternweis P.C., Ranganathan R. A global analysis of crosstalk in a mammalian cellular signalling network. Nat. Cell Biol. 2006, 8:571-580.
34. Park W.Y., Goodman R.B., Steinberg K.P., Ruzinski J.T., Radella F.I.I., Park D.R., Pugin J., Skerrett S.J., Hudson L.D., Martin T.R. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2001, 164:1896-1903.
35. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., Stern E.J., Hudson L.D. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005, 353:1685-1693.
36. Selig W.M., Patterson C.E., Henry D.P., Rhoades R.A. Role of histamine in acute oleic acid-induced lung injury. J. Appl. Physiol. 1986, 61:233-239.
37. Stork P.J., Schmitt J.M. Crosstalk between cAMP andMAPkinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002, 12:258-266.
38. Sugino N., Karube-Harada A., Sakata A., Takiguchi S., Kato H. Different mechanisms for the induction of copper-zinc superoxide dismutase and manganese superoxide dismutase by progesterone in human endometrial stromal cells. Hum. Reprod. 2002, 17:1709-1714.
39. Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr. Opin. Clin. Nutr. Metab. Care 2003, 6:79-85.
40. Tyml K., Li F., Wilson J.X. Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism. Crit. Care Med. 2008, 36:2355-2362.
41. Wang W., Suzuki Y., Tanigaki T., Rank D.R., Raffin T.A. Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs. Am. J. Respir. Crit. Care Med. 1994, 150:1449-1452.
42. Ware L.B., Matthay M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 2000, 342:1334-1349.
43. Wei X., Liu H., Sun X., Fu F., Zhang X., Wang J., An J., Ding H. Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci. Lett. 2005, 386:58-62.
44. Welbourn C.R., Goldman G., Paterson I.S., Valeri C.R., Shepro D., Hechtman H.B. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br. J. Surg. 1991, 78:651-655.
45. Wu F., Schuster D.P., Tyml K., Wilson J.X. Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells. Free Radic. Biol. Med. 2007, 42:124-131.
46. Wu Y., Wang L., Jin M., Zang B.X. Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury. Biol. Pharm. Bull. 2012, 35:515-522.
47. Wyche K.E., Wang S.S., Griendling K.K., Dikalov S.I., Austin H., Rao S., Fink B., Harrison D.G., Zafari A.M. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 2004, 43:1246-1251.
48. Yang C., Moriuchi H., Takase J., Ishitsuka Y., Irikura M., Irei T. Oxidative stress in early stage of acute lung injury induced with oleic acid in guinea pigs. Biol. Pharm. Bull. 2003, 26:424-428.
49. Zhou Z., Kozlowski J., Schuster D.P. Physiologic, biochemical, and imaging characterization of acute lung injury in mice. Am. J. Respir. Crit. Care Med. 2005, 172:344-351.